Porvair’s membrane filters ensure higher flow rates
Designed to withstand pressure during filtration
The rigorous construction of these pleated membrane cartridges ensures higher flow rates, lower pressure differentials and faster process times, the company says. Independently verified to meet USP Class VI and ISO 10993, each filter is provided with a certificate of quality. Manufacturing takes place in an ISO Class 5 cleanroom in accordance with accredited quality procedures and the membrane is protected from damage during production by the inner and outer drainage layers that maintain the pleat pack structure.
The filter's inner core comprises a thermoplastic material that further supports the pleat pack and draws the filtrate through its perforations to the outlet of the cartridge. Snugly encased in a polymeric outer cage and securely fitted with sanitary design adaptors that provide optimal sealing and safety against bypass, each cartridge is identified by a serial number embossed on the outer sleeve, providing full traceability to all FDA CFR 21 and EC-approved manufacturing components.
The supply chain is closely monitored with in-house production of the filter’s outer cage, core and end cap. Careful attention to package design minimises the chance of damage to the filters during transit and storage, says Porvair.
Assurance of the high quality of Porvair membrane cartridge filters is further demonstrated by post-manufacture integrity testing, which is a non-destructive means of determining oversized pores or defects.
The integrity test parameters employed by Porvair are correlated to the filter's microbial retention capabilities as determined during validation in accordance with ASTM F838-05, HIMA and PDA Technical Reports 26 and 40. Any filter that fails integrity testing is immediately discarded.
Porvair Filtration Group is an international leader in the development and supply of materials and products for applications in filtration and separation. It has offices and manufacturing sites in the UK, Europe and the US and a worldwide network of distributors.
You may also like
Manufacturing
Cellevate achieves ISO 9001:2015 certification alongside GMP production processes in new cleanroom
Read moreThe certification caps off a strong 2025 for the company, which now has a scalable foundation for expanding manufacturing capacity and implementing GMP-ready processes for commercial volumes
Trending Articles
You may also like
Manufacturing
Cellevate achieves ISO 9001:2015 certification alongside GMP production processes in new cleanroom
The certification caps off a strong 2025 for the company, which now has a scalable foundation for expanding manufacturing capacity and implementing GMP-ready processes for commercial volumes
Manufacturing
LYOVAC® ECO Mode: making pharmaceutical freeze-drying leaner and greener
Following the recent announcement that GEA Lyophil has received third-party certification for the energy-saving credentials of its innovative algorithm for freeze-drying applications, Dr Kevin Robinson caught up with Senior Director of Lyophilization Technology Management, Thomas Beutler, to find out more
Regulatory
Grifols gets nod from European Medicines Agency for entire value chain of Grifols Egypt
The institution's certification endorses the entire plasma value chain under the highest European standards and opens the door for Egypt to, once domestic needs are met, export to other markets including Europe
Regulatory
Regulating innovation: a new focus on digital mental health technologies (DMHTs)
IMed Consultancy’s Benjamin Austin provides a clear understanding of how digital mental health technologies are innovating care and describes the evolving regulatory frameworks that ensure their safety and effectiveness
Regulatory
ten23 health QC lab to support commercial product testing for US customer following FDA approvals
This pivotal regulatory milestone enables FDA-compliant release and stability testing for injectable drug products throughout the clinical and commercial phases, in addition to manufacturing the commercial product
Manufacturing
Particology joins £8.2m consortium to drive greener, more efficient medicines manufacturing
The company has been selected for Innovate UK’s £54m Sustainable Medicines Manufacturing Innovation Programme, leading crystallisation research to cut waste, reduce energy use and accelerate next-generation pharmaceutical production